248 related articles for article (PubMed ID: 17338314)
21. Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination.
Staneck JL; Weckbach LS; Allen SD; Siders JA; Gilligan PH; Coppitt G; Kraft JA; Willis DH
J Clin Microbiol; 1996 Nov; 34(11):2718-21. PubMed ID: 8897171
[TBL] [Abstract][Full Text] [Related]
22. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.
Shin BM; Lee EJ; Kuak EY; Yoo SJ
Anaerobe; 2009 Dec; 15(6):266-9. PubMed ID: 19772927
[TBL] [Abstract][Full Text] [Related]
23. Detection of Clostridium difficile and its toxin A (TcdA) in stool specimens from hospitalised patients.
Wróblewska MM; Swoboda-Kopeć E; Rokosz A; Nurzyńska G; Bednarska A; Luczak M
Pol J Microbiol; 2005; 54(2):111-5. PubMed ID: 16209104
[TBL] [Abstract][Full Text] [Related]
24. Rapid detection of Clostridium difficile in stool using the VIDASR C. difficile Toxin A II assay.
Lipson SM; Tortora G; Tempone A; Fedorko DP; Spitzer ED
Diagn Microbiol Infect Dis; 2003 Feb; 45(2):117-21. PubMed ID: 12614982
[TBL] [Abstract][Full Text] [Related]
25. Multicentre evaluation of a commercial test for the rapid diagnosis of Clostridium difficile-mediated antibiotic-associated diarrhoea.
Bentley AH; Patel NB; Sidorczuk M; Loy P; Fulcher J; Dexter P; Richards J; Borriello SP; Zak KW; Thorn EM
Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):788-90. PubMed ID: 9923521
[TBL] [Abstract][Full Text] [Related]
26. Clostridium difficile PCR Cycle Threshold Predicts Free Toxin.
Senchyna F; Gaur RL; Gombar S; Truong CY; Schroeder LF; Banaei N
J Clin Microbiol; 2017 Sep; 55(9):2651-2660. PubMed ID: 28615471
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of five commercial tests for the rapid diagnosis of Clostridium difficile-associated disease.
Miendje Deyi VY; Vandenberg O; Mascart G; Gning S; Retore P; Douat N; Dediste A
Clin Lab; 2008; 54(1-2):9-13. PubMed ID: 18510038
[TBL] [Abstract][Full Text] [Related]
28. [Clostridium difficile toxin A and other enteropathogens in stool specimens of children hospitalized due to acute diarrhoea].
Rozkiewicz D; Zaremba ML; Fiedoruk K; Daniluk T; Sciepuk M; Kurzatkowska B; Sulik A; Ołdak E
Przegl Epidemiol; 2005; 59(3):711-21. PubMed ID: 16433313
[TBL] [Abstract][Full Text] [Related]
29. Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens.
Merz CS; Kramer C; Forman M; Gluck L; Mills K; Senft K; Steiman I; Wallace N; Charache P
J Clin Microbiol; 1994 May; 32(5):1142-7. PubMed ID: 8051237
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of four methods for detection of Clostridium difficile or C. difficile toxin: cytotoxin assay, culture, latex agglutination, and a new rapid immunoassay (C. difficile toxin A test).
Fille M; Larcher C; Dierich MP; Allerberger F
Z Gastroenterol; 1998 Feb; 36(2):143-9. PubMed ID: 9544497
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the Clearview Clostridium difficile Toxin A Test and various selective culture media in comparison with the cytotoxin assay for the diagnosis of Clostridium difficile-associated diarrhoea.
Anderson TL; McGregor A
Pathology; 2003 Jun; 35(3):244-7. PubMed ID: 14506970
[TBL] [Abstract][Full Text] [Related]
32. The diagnosis of Clostridium difficile-associated diarrhea: comparison of Triage C. difficile panel, EIA for Tox A/B and cytotoxin assays.
Alfa MJ; Swan B; VanDekerkhove B; Pang P; Harding GK
Diagn Microbiol Infect Dis; 2002 Aug; 43(4):257-63. PubMed ID: 12151184
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the ToxA test with cytotoxicity assay and culture for the detection of Clostridium difficile-associated diarrhoea disease.
Schué V; Green GA; Monteil H
J Med Microbiol; 1994 Nov; 41(5):316-8. PubMed ID: 7966202
[TBL] [Abstract][Full Text] [Related]
34. Development of a rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of C. difficile-associated disease.
DiPersio JR; Varga FJ; Conwell DL; Kraft JA; Kozak KJ; Willis DH
J Clin Microbiol; 1991 Dec; 29(12):2724-30. PubMed ID: 1757540
[TBL] [Abstract][Full Text] [Related]
35. Concordance between two enzyme immunoassays for the detection of Clostridium difficile toxins.
Herrera-Cáceres JO; Camacho-Ortiz A; Galindo-Fraga A; Hernández-Durán M; Cordero-Rangel A; Hernández-Cruz A; Bobadilla-del Valle M; Ponce-de-León A; Sifuentes-Osornio J
Arch Med Res; 2010 Feb; 41(2):92-6. PubMed ID: 20470937
[TBL] [Abstract][Full Text] [Related]
36. Diagnosing toxigenic Clostridium difficile: new confidence bounds show culturing increases sensitivity of the toxin A/B enzyme immunoassay and refute gold standards.
Mattner F; Winterfeld I; Mattner L
Scand J Infect Dis; 2012 Aug; 44(8):578-85. PubMed ID: 22404319
[TBL] [Abstract][Full Text] [Related]
37. Rapid Detection of Clostridium difficile Toxins in Stool by Raman Spectroscopy.
Koya SK; Yurgelevic S; Brusatori M; Huang C; Diebel LN; Auner GW
J Surg Res; 2019 Dec; 244():111-116. PubMed ID: 31279995
[TBL] [Abstract][Full Text] [Related]
38. Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease.
Lee SD; Turgeon DK; Ko CW; Fritsche TR; Surawicz CM
Am J Gastroenterol; 2003 Jul; 98(7):1569-72. PubMed ID: 12873579
[TBL] [Abstract][Full Text] [Related]
39. Lack of value of repeat stool testing for Clostridium difficile toxin.
Mohan SS; McDermott BP; Parchuri S; Cunha BA
Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
[TBL] [Abstract][Full Text] [Related]
40. [Clostridium difficile TOX A/B II TEST evaluation].
Sugiura H; Kaneko T; Sumita M; Onozaki M; Sakamoto F; Osaki K; Taguchi H; Kamiya S; Takeda K
Kansenshogaku Zasshi; 2009 Sep; 83(5):513-8. PubMed ID: 19860252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
